Preston Klassen

Insider Reports History

Location
San Diego, CA
Signature
/s/ Christopher Aker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Preston Klassen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Metacrine, Inc. Director Common Stock 1,384,116 $650,535 $0.4700 23 Mar 2023 Direct
Regulus Therapeutics Inc. President & Head of R & D, Director Common Stock 0 $0 $7.93 25 Jun 2025 Direct
Regulus Therapeutics Inc. President & Head of R & D, Director Stock Option (Right to Buy) 675,000 30 Jan 2025 Direct
Metacrine, Inc. Director Stock Option (right to buy) 0 23 Mar 2023 Direct
Regulus Therapeutics Inc. President & Head of R & D, Director Stock Option 0 25 Jun 2025 Direct

Insider Reports Filed by Preston Klassen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGLS Regulus Therapeutics Inc. 25 Jun 2025 6 $0 4 President & Head of R & D, Director 27 Jun 2025, 17:06
RGLS Regulus Therapeutics Inc. 03 Jun 2025 1 +$95,852 4 President & Head of R & D, Director 04 Jun 2025, 17:00
RGLS Regulus Therapeutics Inc. 30 Jan 2025 1 $0 4 President & Head of R & D, Director 31 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 13 Jan 2025 1 -$39,721 4 President & Head of R & D, Director 15 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 09 Jan 2025 2 +$90,000 4 President & Head of R & D, Director 10 Jan 2025, 17:00
RGLS Regulus Therapeutics Inc. 20 May 2024 1 $0 4 President & Head of R & D, Director 21 May 2024, 16:22
RGLS Regulus Therapeutics Inc. 12 Jan 2024 1 $0 4 President & Head of R & D, Director 17 Jan 2024, 17:18
RGLS Regulus Therapeutics Inc. 10 Aug 2023 1 $0 4 President & Head of R & D, Director 14 Aug 2023, 16:24
RGLS Regulus Therapeutics Inc. 12 Jun 2023 1 $0 4 President & Head of R & D 12 Jun 2023, 16:48
RGLS Regulus Therapeutics Inc. 12 Jun 2023 0 $0 3 President & Head of R & D 12 Jun 2023, 16:45
/report/000120919123020882-klassen-preston-2023-03-23 Metacrine, Inc. 23 Mar 2023 2 -$395,839 4 Director 24 Mar 2023, 12:35
ZURA Zura Bio Ltd 20 Mar 2023 0 $0 3 President and COO 21 Mar 2023, 19:35
/report/000120919123005271-klassen-preston-2023-01-26 Metacrine, Inc. 26 Jan 2023 1 -$157,266 4 President & CEO, Director 27 Jan 2023, 15:42
/report/000120919122024951-klassen-preston-2022-04-19 Metacrine, Inc. 19 Apr 2022 2 -$22,472 4 President & CEO, Director 20 Apr 2022, 16:25
/report/000120919122024631-klassen-preston-2022-04-14 Metacrine, Inc. 14 Apr 2022 1 $0 4 President & CEO, Director 18 Apr 2022, 17:28
/report/000120919122014081-klassen-preston-2022-02-27 Metacrine, Inc. 27 Feb 2022 2 $0 4 President & CEO, Director 01 Mar 2022, 15:56
/report/000120919121034596-klassen-preston-2021-05-20 Metacrine, Inc. 20 May 2021 1 +$74,692 4 President & CEO, Director 20 May 2021, 18:55